ethyl 3-(difluoromethyl)-1H-pyrazole-5-carboxylate, 95.0%, 250mg

(2-Phenoxybenzyl)hydrazine hydrochloride, 97.0%, 1g

Trimethyloxonium tetrafluoroborate, 97.0%, 1g

2-Ethoxy-3-isopropylpyrazine, 95.0%, 5g

Methyl 5-((tert-butoxycarbonyl)amino)thiazole-2-carboxylate, 98%, 250mg

(S)-3,5-dichloro-N-((1-ethylpyrrolidin-2-yl)methyl)-2,6-dihydroxybenzamide, 98%, 250mg

8-(TRIFLUOROMETHYL)-2,3-DIHYDROISOQUINOLIN-3-ONE, 95%, 250mg

4-(Naphthalen-2-ylmethyl)piperidine, 95%, 500mg

(1-FLUOROCYCLOPROPYL)METHANOL, 95.0%, 5g

2-(chloromethyl)-1,4-dimethylbenzene, 97.0%, 5g

3,5-dibromo-1-[(3-bromophenyl)methyl]-1H-1,2,4-triazole, 95.0%, 1g

GC capillary column ROTI®Cap-FFAP, 50 m, 0.25 mm, 0.25 µm, 1 Piece(s)

Methyl 4-benzylmorpholine-3-carboxylate, 95.0%, 25g